These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25924970)

  • 1. Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010.
    Guren MG; Kørner H; Pfeffer F; Myklebust TÅ; Eriksen MT; Edna TH; Larsen SG; Knudsen KO; Nesbakken A; Wasmuth HH; Vonen B; Hofsli E; Færden AE; Brændengen M; Dahl O; Steigen SE; Johansen MJ; Lindsetmo RO; Drolsum A; Tollåli G; Dørum LM; Møller B; Wibe A
    Acta Oncol; 2015 Nov; 54(10):1714-22. PubMed ID: 25924970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved local control of rectal cancer reduces distant metastases.
    Bernstein TE; Endreseth BH; Romundstad P; Wibe A;
    Colorectal Dis; 2012 Oct; 14(10):e668-78. PubMed ID: 22646752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
    Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the choice of hospital increase a chance of survival in rectal cancer?
    Pawlak M; Morawiec Z; Dziki Ł; Morawiec J; Kolacińska A; Dziki A
    Pol Przegl Chir; 2012 Dec; 84(12):638-45. PubMed ID: 23399631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends, improvements and national auditing of rectal cancer management over an 18-year period.
    Kodeda K; Johansson R; Zar N; Birgisson H; Dahlberg M; Skullman S; Lindmark G; Glimelius B; Påhlman L; Martling A
    Colorectal Dis; 2015 Sep; 17(9):O168-79. PubMed ID: 26155848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
    Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a multidisciplinary team training programme on rectal cancer outcomes in Spain.
    Ortiz H; Wibe A; Ciga MA; Lujan J; Codina A; Biondo S;
    Colorectal Dis; 2013 May; 15(5):544-51. PubMed ID: 23351018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.
    Wiegering A; Isbert C; Dietz UA; Kunzmann V; Ackermann S; Kerscher A; Maeder U; Flentje M; Schlegel N; Reibetanz J; Germer CT; Klein I
    BMC Cancer; 2014 Nov; 14():816. PubMed ID: 25376382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.
    Wibe A; Møller B; Norstein J; Carlsen E; Wiig JN; Heald RJ; Langmark F; Myrvold HE; Søreide O;
    Dis Colon Rectum; 2002 Jul; 45(7):857-66. PubMed ID: 12130870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer.
    Palmer G; Martling A; Cedermark B; Holm T
    Colorectal Dis; 2011 Dec; 13(12):1361-9. PubMed ID: 20958913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
    Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
    Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer treatment of the elderly.
    Endreseth BH; Romundstad P; Myrvold HE; Bjerkeset T; Wibe A;
    Colorectal Dis; 2006 Jul; 8(6):471-9. PubMed ID: 16784465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological outcome following anastomotic leak in rectal surgery.
    Espín E; Ciga MA; Pera M; Ortiz H;
    Br J Surg; 2015 Mar; 102(4):416-22. PubMed ID: 25619499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of surgery on metachronous distant metastases and survival in rectal cancer.
    Köckerling F; Reymond MA; Altendorf-Hofmann A; Dworak O; Hohenberger W
    J Clin Oncol; 1998 Jan; 16(1):324-9. PubMed ID: 9440760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical disparities of rectal cancer local recurrence and outcomes: a population-based analysis.
    Helewa RM; Turner D; Wirtzfeld D; Park J; Hochman DJ; Czaykowski P; Ahmed S; Shu E; McKay A
    Dis Colon Rectum; 2013 Jul; 56(7):850-8. PubMed ID: 23739191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of anastomotic leak on recurrence and survival after colorectal cancer surgery: a BioGrid Australia analysis.
    Sammour T; Hayes IP; Jones IT; Steel MC; Faragher I; Gibbs P
    ANZ J Surg; 2018 Jan; 88(1-2):E6-E10. PubMed ID: 27255690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.